COPD

New phase 3 ENHANCE-2 data support a potential submission by Verona Pharma to the FDA.

Though current use rates have declined since 2017, investigators believe more young adults are transitioning from experimental to habitual use.

Early follow-up in patients with COPD led to lower rates of readmissions at 90 days, while patients with CHF saw lower 90-day mortality.

Dr. Trudzinski speaks of the importance of diagnosing sex-specific pulmonary and extra-pulmonary comorbidities in women with COPD, as well as the lack of research regarding COPD prevalence in women.

Dr. Richmond speaks to the newest pulmonology data from Vanderbilt University that was presented at ATS 2022.

Previously, the US Preventive Services Task Force reviewed screening evidence for COPD in 2016 and issued a D recommendation against screening in asymptomatic adults.

The 2022 State of the Air report from the American Lung Association highlights growing disparities in coastal-based ozone and particle pollution, amid wildfires and shifts in regulatory policies.

Overall tobacco use declined among adults since 2019—but many from varying sociodemographic backgrounds are still reporting high use.

The inhaler is approved for 2 strengths, 160/4.5 mcg/actuation and 80/4.5 mcg/actuation.

Dr. Shrine and colleagues conducted the largest genome-wide association study of coexisting asthma and COPD to date in a 2-stage design incorporating a total of 13 studies.

Take a Break was a 3-week interactive experience that involved motivational text messages, challenge quizzes, brief goal setting and more.

The discriminative accuracy of the 3 instruments were evaluated in low- and middle-income settings in Nepal, Peru, and Uganda, with further research needed to determine whether implementation is associated with improved clinical outcomes.

Dr. Castro talks of the available biologic therapies that can be used to treat asthma and other respiratory disorders.

Investigators found that exposure to surgical smoke and disinfectants over a long period of time led to increased risk of COPD in US female nurses.

Investigators believe the current climate crisis can lead to an increased risk of COPD exacerbations and mortality rates, both of which have been noted in prior research.

Investigators have found a negative association between the COPD and proton pump inhibitors through a familiar sequence symmetry analysis approach used to find associations between COPD and gastro-esophageal reflux disease.

Researchers note the severity of the disease significantly impacts patients’ sleep habits, medication intake, and general mental and physical health.

While investigators did not meet their primary endpoint in the study, results in former smokers within the trial were promising and prompted further research on the subgroup.

A team of investigators stress the impact of the disease on patients as mortality rates grow worldwide.

An expert discussion on climate change and air pollution effects on communities, including increased COVID-19 rates.

Meredith McCormack, MD discusses consequences of high air pollution levels in the United States found in the 2021 American Lung Association State of the Air Report.

The 2021 annual report finds that Los Angeles remains the most polluted US city, while negative impacts of climate change and COVID-19 are both linked to increased pollution rates.

The non-invasive device uses air pressure pulsations to help open airways and provide clearance of secretions in patients with disease such as COPD, asthma, and cystic fibrosis.

More than two-thirds of smokers want to quit, but lack proper resources. A prescribing professional could help make up that difference.

Even study enrollees who never smoked traditional cigarettes face a heightened risk of respiratory disease if they used e-cigarettes.

Investigators conducted an educational intervention aimed at strengthening healthcare providers’ readiness to address issues related to medication adherence.

New data show patients hospitalized with COVID-19 far more frequently suffer from cardiometabolic disease, yet face worse outcomes with COPD.

The trial did not reach full enrollment.

Pulmonary conditions like asthma could often lead to the development of chronic cough.